BRAF, FIGN and RTL1 gene signatures identified in murine hepatocellular carcinoma had relevance in human liver disease; BRAF and RTL1 were downregulated while FIGN was upregulated in patients and provided means to stratify these patients according to disease phenotype, stage and disease-free survival. Here, RTL1 is linked to hepatocellular carcinoma.